Company: STAA
Filing Date: 2025-10-30
Form Type: DEFA14A
Source: 0001193125-25-258558
Chunk: 12

Company: STAAR SURGICAL CO
Filing Date: 2025-10-30
Form: DEFA14A
Chunk 12
---
 the Broadwood Group filed a preliminarydefinitive proxy statement with the SEC to solicit votes of STAAR stockholders in opposition to the
Board’s recommendations on the Merger Proposal and Compensation Proposal presented in this proxy statement. If STAAR’s largest stockholders do not vote their shares in support of the adoption of the Merger Agreement, STAAR’s
ability to satisfy this closing condition would be materially adversely affected. Further, STAAR may be unable to obtain the votes required to approve these proposals in the absence of any change to the terms of the Merger Agreement.
The proxy contest resulting from the Broadwood Group filing will cause STAAR stockholders to incur additional solicitation and other costs, and may impair STAAR’s ability to obtain the votes required to approve the Merger Proposal and
Compensation Proposal.

The section of the Summary titled “Required Stockholder Approval” on page 7 of the proxy statement is hereby amended and supplemented as follows:

Required Stockholder Approval

The affirmative vote “FOR” the adoption of the Merger Agreement by the holders of a majority of the outstanding shares of
STAAR common stock entitled to vote thereon (the “Stockholder Approval”) is required to approve the Merger Proposal. As of the close of business on September12 October24, 2025 (the “Record Date”), the affirmative vote of 24,677,06224,682,912 shares of STAAR common stock constitutes a vote by the
majority of the outstanding shares of STAAR common stock. Receipt of the Stockholder Approval is a condition to the consummation of the Merger.

Assuming a quorum is present, the affirmative vote of the holders of the shares of STAAR common stock representing a majority of the STAAR
common stock present by remote communication or represented by proxy at the Special Meeting and entitled to vote on the Compensation Proposal (as defined below) is required for approval of, on an advisory (nonbinding) basis, the proposal to approve
compensation that may be paid or become payable to STAAR’s named executive officers that is based on or otherwise related to the Merger Agreement and the transactions contemplated by the Merger Agreement (which this proxy statement refers to
as the “Compensation Proposal”).

As of the Record Date, STAAR’s executive officers and directors beneficially owned and
were entitled to vote, in the aggregate, approximately 123,542 shares of STAAR common stock, representing less than 1% of the shares of STAAR common stock outstanding on the